To RAS or Not to RAS? The Evidence for and Cautions with Renin-Angiotensin System Inhibition in Patients with Diabetic Kidney Disease.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 496, doi. 10.1002/phar.1232
- By:
- Publication type:
- Article
Works matching IS 02770008 AND DT 2013 AND VI 33 AND IP 5
Results: 16
1
2
Targeting Potassium Channels Kv1.3 and K<sub>C</sub><sub>a</sub>3.1: Routes to Selective Immunomodulators in Autoimmune Disorder Treatment?
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 515, doi. 10.1002/phar.1236
- By:
- Publication type:
- Article
3
Additional Economic and Pharmacokinetic Considerations of Intravenous Acetaminophen in Acutely Ill Patients.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. e83, doi. 10.1002/phar.1199_1
- By:
- Publication type:
- Article
4
Authors' Reply.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. e84, doi. 10.1002/phar.1199_2
- By:
- Publication type:
- Article
5
Discharge Counseling for Patients with Heart Failure or Myocardial Infarction: A Best Practices Model Developed by Members of the American College of Clinical Pharmacy's Cardiology Practice and Research Network Based on the Hospital to Home ( H2 H) Initiative
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 558, doi. 10.1002/phar.1231
- By:
- Publication type:
- Article
6
Use of Preoperative CHA<sub>2</sub> DS<sub>2</sub>- VASc Score to Predict the Risk of Atrial Fibrillation After Cardiothoracic Surgery: A Nested Case-Control Study from the Atrial Fibrillation Suppression Trials ( AFIST) I, II, and III.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 489, doi. 10.1002/phar.1235
- By:
- Publication type:
- Article
7
Authors' Reply.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. e86, doi. 10.1002/phar.1200_2
- By:
- Publication type:
- Article
8
Over-the-Counter Access to Emergency Contraception without Age Restriction: An Opinion of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 549, doi. 10.1002/phar.1229
- By:
- Publication type:
- Article
9
Abstracts from the American College of Clinical Pharmacy 2013 Virtual Poster Symposium.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. e50, doi. 10.1002/phar.1300
- Publication type:
- Article
10
Timing of Factor VIIa in Liver Transplantation Impacts Cost and Clinical Outcomes.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 483, doi. 10.1002/phar.1230
- By:
- Publication type:
- Article
11
Antihypertensive Drugs and the Risk of Congenital Anomalies.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 476, doi. 10.1002/phar.1212
- By:
- Publication type:
- Article
12
Pseudoephedrine and False-Positive Immunoassay Urine Drug Tests for Amphetamine.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. e88, doi. 10.1002/phar.1216
- By:
- Publication type:
- Article
13
Economic Analysis of Alvimopan-A Clarification and Commentary.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. e81, doi. 10.1002/phar.1193
- By:
- Publication type:
- Article
14
Severe Prolonged Sedation Associated with Coadministration of Protease Inhibitors and Intravenous Midazolam During Bronchoscopy: A Commentary.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. e85, doi. 10.1002/phar.1200_1
- By:
- Publication type:
- Article
15
The Evolving Role of Antifungal Susceptibility Testing.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 465, doi. 10.1002/phar.1233
- By:
- Publication type:
- Article
16
Clinical Pharmacy Services in Heart Failure: An Opinion Paper from the Heart Failure Society of America and American College of Clinical Pharmacy Cardiology Practice and Research Network.
- Published in:
- Pharmacotherapy, 2013, v. 33, n. 5, p. 529, doi. 10.1002/phar.1295
- By:
- Publication type:
- Article